AGENUS INC (AGEN) — Inside-Filings

Sentiment-Signal

30,5

Bearisch

Composite Score (0–100)

Insider (25%)

Keine Insider-Käufe

Institutionell (22,5%)

25.3

Keine neuen Positionen

Aktivist (12,5%)

Kein 13D/13G

Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)

Score-Verlauf (90 Tage)

Stammdaten

Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs comprising Prophage vaccine candidate; and QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. The company also develops Balstilimab, an anti-PD-1 antagonist that has completed Phase II clinical trial to treat second line cervical cancer; AGEN1181, an anti-CTLA-4 monospecific antibody that is in Phase 1/2 clinical trial; AGEN2373, an anti-CD137 monospecific antibody that is in Phase 1 clinical trial; AGEN1423, a tumor microenvironment conditioning anti-CD73/TGFß TRAP bi-functional antibody that has completed Phase 1 clinical trial; AGEN1777, an anti-TIGIT bispecific antibodies; and AGEN1327, a human monoclonal antibody. In addition, the company develops INCAGN1876, an anti-GITR monospecific antibody; INCAGN1949, an anti-OX40 monospecific antibody; INCAGN2390, an anti-TIM-3 monospecific antibody; INCAGN2385, an anti-LAG-3 monospecific antibody; MK-4830, a monospecific antibody targeting ILT4; AGENT 797, an iNKT cells that is in Phase 1 clinical trial for solid tumors, multiple myeloma, and viral ARDS, as well as in clinical stage to treat hematological malignancies and multiple myeloma/B cells; and AGEN1884, a first-generation anti-CTLA-4 monospecific antibody. Agenus Inc. operates under ASV, Agenus, AutoSynVax, EVAMPLIX, MiNK, PSV, PhosPhoSynVax, Prophage, Retrocyte Display, and Stimulon trademarks. It has collaborations with Incyte Corporation, Merck Sharpe & Dohme, Recepta Biopharma SA, and Gilead Sciences, Inc. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.

Unternehmen & Branche

Name	AGENUS INC
Ticker	AGEN
CIK	0001098972
Boerse	US
Sektor	Healthcare
Industrie	Biotechnology
SIC	2836 · Biological Products, (No Diagnostic Substances)

Wertpapier & Kennzahlen

CUSIP	00847G705
ISIN	US00847G7051
Typ	Common Stock
Marktkapitalisierung	145,7 Mio. USD
Beta	1,61
Dividendenrendite	0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

Periode	Filing	Umsatz	EPS	Aktiva	Eigenkapital
2025-12-31	10-K	114,196,000	0.00	226,798,000	-271,111,000
2025-09-30	10-Q	30,235,000	1.94	233,891,000	-274,137,000
2025-06-30	10-Q	25,691,000	-1.00	185,221,000	-354,601,000
2025-03-31	10-Q	24,066,000	-1.03	200,201,000	-341,848,000
2024-12-31	10-K	103,463,000	-10.59	226,271,000	-326,380,000
2024-09-30	10-Q	25,112,000	-3.08	238,482,000	-292,336,000
2024-06-30	10-Q	23,509,000	-2.52	292,415,000	-241,311,000
2024-03-31	10-Q	28,005,000	-3.04	256,559,000	-201,430,000
2023-12-31	10-K	156,314,000	-13.75	313,913,000	-160,331,000
2023-09-30	10-Q	24,314,000	-3.29	335,472,000	-129,112,000
2023-06-30	10-Q	25,296,000	-3.93	383,593,000	-93,195,000
2023-03-31	10-Q	22,902,000	-4.31	412,854,000	-58,536,000
2022-12-31	10-K	98,024,000	-15.64	413,556,000	-61,278,000
2022-09-30	10-Q	22,772,000	-0.19	429,019,000	-20,385,000
2022-06-30	10-Q	20,926,000	-0.17	456,174,000	3,416,000
2022-03-31	10-Q	25,941,000	-0.19	441,305,000	15,718,000
2021-12-31	10-K	295,665,000	-0.11	465,958,000	34,440,000
2021-09-30	10-Q	252,954,000	0.72	437,639,000	41,854,000
2021-06-30	10-Q	10,730,000	-0.37	192,299,000	-247,118,000
2021-03-31	10-Q	11,719,000		234,915,000	-189,660,000

Fondsaktivität (Vorquartalsvergleich)

Fonds	Aktuell (Stk)	Veränderung (Stk)	Wert (USD)	Status	Δ
VANGUARD GROUP INC	2,830,736	2,830,736	8,888,511	Neu	+100,0%
Siren, L.L.C.	1,064,250	1,064,250	3,341,745	Neu	+100,0%
BlackRock, Inc.	558,345	558,345	1,753,204	Neu	+100,0%
RENAISSANCE TECHNOLOGIES LLC	543,546	543,546	1,706,734	Neu	+100,0%
CITADEL ADVISORS LLC	522,442	522,442	1,640,468	Neu	+100,0%
GEODE CAPITAL MANAGEMENT, LLC	372,748	372,748	1,171,219	Neu	+100,0%
MORGAN STANLEY	285,198	285,198	895,521	Neu	+100,0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP	283,974	283,974	891,678	Neu	+100,0%
MILLENNIUM MANAGEMENT LLC	225,339	225,339	707,564	Neu	+100,0%
PANAGORA ASSET MANAGEMENT INC	163,148	163,148	512,285	Neu	+100,0%
MARSHALL WACE, LLP	146,800	146,800	460,952	Neu	+100,0%
RAYMOND JAMES FINANCIAL INC	141,653	141,653	444,790	Neu	+100,0%
STATE STREET CORP	137,383	137,383	431,383	Neu	+100,0%
D. E. Shaw & Co., Inc.	127,638	127,638	400,783	Neu	+100,0%
Walleye Capital LLC	123,458	123,458	387,658	Neu	+100,0%
UBS Group AG	118,818	118,818	373,088	Neu	+100,0%
TWO SIGMA INVESTMENTS, LP	117,117	117,117	367,747	Neu	+100,0%
683 Capital Management, LLC	114,336	114,336	359,015	Neu	+100,0%
Man Group plc	114,204	114,204	358,601	Neu	+100,0%
NORTHERN TRUST CORP	89,586	89,586	281,301	Neu	+100,0%
JANE STREET GROUP, LLC	85,272	85,272	267,754	Neu	+100,0%
GROUP ONE TRADING LLC	75,639	75,639	237,506	Neu	+100,0%
Connor, Clark & Lunn Investment Management Ltd.	67,959	67,959	213,391	Neu	+100,0%
CANADA PENSION PLAN INVESTMENT BOARD	66,100	66,100	207,554	Neu	+100,0%
GOLDMAN SACHS GROUP INC	61,749	61,749	193,892	Neu	+100,0%
Susquehanna Portfolio Strategies, LLC	59,413	59,413	186,557	Neu	+100,0%
SIMPLEX TRADING, LLC	55,400	55,400	173,956	Neu	+100,0%
Squarepoint Ops LLC	55,142	55,142	173,146	Neu	+100,0%
ExodusPoint Capital Management, LP	47,461	47,461	149,028	Neu	+100,0%
BARCLAYS PLC	46,273	46,273	145,297	Neu	+100,0%
Qube Research & Technologies Ltd	39,895	39,895	125,270	Neu	+100,0%
Engineers Gate Manager LP	35,279	35,279	110,776	Neu	+100,0%
Graham Capital Management, L.P.	31,706	31,706	99,557	Neu	+100,0%
Ovata Capital Management Ltd	30,800	30,800	96,712	Neu	+100,0%
OSAIC HOLDINGS, INC.	27,139	27,139	85,216	Neu	+100,0%
LPL Financial LLC	23,326	23,326	73,244	Neu	+100,0%
HSBC HOLDINGS PLC	17,056	17,056	54,239	Neu	+100,0%
Quadrature Capital Ltd	17,121	17,121	53,760	Neu	+100,0%
BANK OF MONTREAL /CAN/	16,207	16,207	50,890	Neu	+100,0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	15,061	15,061	47,292	Neu	+100,0%
BANK OF AMERICA CORP /DE/	13,246	13,246	41,592	Neu	+100,0%
R Squared Ltd	13,129	13,129	41,225	Neu	+100,0%
Post Resch Tallon Group Inc.	12,750	12,750	40,035	Neu	+100,0%
AQR CAPITAL MANAGEMENT LLC	11,576	11,576	36,348	Neu	+100,0%
WELLS FARGO & COMPANY/MN	10,184	10,184	31,976	Neu	+100,0%
MSA Advisors, LLC	10,000	10,000	31,400	Neu	+100,0%
Tower Research Capital LLC (TRC)	8,402	8,402	26,382	Neu	+100,0%
FMR LLC	5,429	5,429	17,047	Neu	+100,0%
First Command Advisory Services, Inc.	3,530	3,530	11,084	Neu	+100,0%
Pinnacle Wealth Planning Services, Inc.	3,373	3,373	10,591	Neu	+100,0%

Insider-Transaktionen (12 Monate)

Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.

Top-Fondshalter

Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.

Fonds	Anteile	Wert (USD)	Anteil (%)
VANGUARD GROUP INC	2,830,736	8,888,511	31.25
Siren, L.L.C.	1,064,250	3,341,745	11.75
BlackRock, Inc.	558,345	1,753,204	6.16
RENAISSANCE TECHNOLOGIES LLC	543,546	1,706,734	6.00
CITADEL ADVISORS LLC	522,442	1,640,468	5.77
GEODE CAPITAL MANAGEMENT, LLC	372,748	1,171,219	4.12
MORGAN STANLEY	285,198	895,521	3.15
SUSQUEHANNA INTERNATIONAL GROUP, LLP	283,974	891,678	3.13
MILLENNIUM MANAGEMENT LLC	225,339	707,564	2.49
PANAGORA ASSET MANAGEMENT INC	163,148	512,285	1.80
MARSHALL WACE, LLP	146,800	460,952	1.62
RAYMOND JAMES FINANCIAL INC	141,653	444,790	1.56
STATE STREET CORP	137,383	431,383	1.52
D. E. Shaw & Co., Inc.	127,638	400,783	1.41
Walleye Capital LLC	123,458	387,658	1.36
UBS Group AG	118,818	373,088	1.31
TWO SIGMA INVESTMENTS, LP	117,117	367,747	1.29
683 Capital Management, LLC	114,336	359,015	1.26
Man Group plc	114,204	358,601	1.26
NORTHERN TRUST CORP	89,586	281,301	0.99